News

Venaxis to Present at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum

Venaxis, Inc. today announced it will be presenting at the Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum being held in New York on November 20, 2014.  Read more…



Venaxis’ APPY1 Trial Results Presented by Dr. David S. Huckins, M.D., at ACEP14

Venaxis, Inc. today announced results of the company’s pivotal APPY1 Test clinical trial were presented at the American College of Emergency Physicians Scientific Assembly 2014 (ACEP14). The trial involved 29 U.S. hospital sites recruiting patients aged 2 – 20 from January 2013 through January 2014. Results were presented by Lead Principal Investigator Dr. David S. Huckins, M.D.  Read more…



Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14

Venaxis, Inc. today announced that results of the company’s pivotal APPY1 clinical trial will be presented by Dr. David S. Huckins, M.D., Lead Principal Investigator, at the American College of Emergency Physicians Scientific Assembly 2014 (ACEP14).  Read more…